scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PNAS..10514585P |
P356 | DOI | 10.1073/PNAS.0805048105 |
P932 | PMC publication ID | 2567192 |
P698 | PubMed publication ID | 18794525 |
P5875 | ResearchGate publication ID | 23258191 |
P50 | author | Anton Y. Peleg | Q42220362 |
Eleftherios Mylonakis | Q56769876 | ||
Beth Burgwyn Fuchs | Q63406367 | ||
P2093 | author name string | Emmanouil Tampakakis | |
Robert C Moellering | |||
George M Eliopoulos | |||
P2860 | cites work | Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals | Q28292772 |
Antifungal chemical compounds identified using a C. elegans pathogenicity assay | Q28469125 | ||
An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants | Q29614860 | ||
Nonfilamentous C. albicans mutants are avirulent | Q29617839 | ||
Bacterial diversity within the human subgingival crevice | Q30824037 | ||
Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi | Q30833128 | ||
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p | Q33217380 | ||
NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction | Q34077791 | ||
Geomicrobiology: how molecular-scale interactions underpin biogeochemical systems. | Q34127929 | ||
Pseudomonas-Candida interactions: an ecological role for virulence factors | Q34134632 | ||
Regulatory roles of the GacS/GacA two-component system in plant-associated and other gram-negative bacteria. | Q34478683 | ||
Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis | Q35677298 | ||
Unveiling molecular scaffolds of the type IV secretion system | Q35695002 | ||
Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans | Q35783931 | ||
Developing animal models for polymicrobial diseases | Q35805388 | ||
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection | Q36370514 | ||
Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii | Q36594556 | ||
Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate | Q36998159 | ||
Tyrosol is a quorum-sensing molecule in Candida albicans | Q37416044 | ||
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. | Q39491534 | ||
Candida albicans biofilm-defective mutants | Q42975323 | ||
The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans | Q44120428 | ||
Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System | Q44727502 | ||
A bacterial cell-cell communication signal with cross-kingdom structural analogues | Q44734077 | ||
The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action | Q45024753 | ||
Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicans | Q45035952 | ||
A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology | Q45156903 | ||
Control of filament formation in Candida albicans by the transcriptional repressor TUP1. | Q46154938 | ||
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog | Q48077116 | ||
Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. | Q51118421 | ||
Evolution of species interactions in a biofilm community | Q59055799 | ||
Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal components | Q80396601 | ||
P433 | issue | 38 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Caenorhabditis elegans | Q91703 |
P304 | page(s) | 14585-14590 | |
P577 | publication date | 2008-09-15 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans | |
P478 | volume | 105 |
Q92733350 | A New Front in Microbial Warfare-Delivery of Antifungal Effectors by the Type VI Secretion System |
Q64060527 | A Novel Virulence Phenotype Rapidly Assesses Fungal Pathogenesis in Healthy and Immunocompromised Hosts |
Q54384104 | A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. |
Q90350054 | A multimodel regime for evaluating effectiveness of antimicrobial wound care products in microbial biofilms |
Q38008459 | Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models |
Q35154057 | Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection |
Q38840796 | An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs |
Q90589434 | Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms |
Q46490376 | Binary Interactions of Antagonistic Bacteria with Candida albicans Under Aerobic and Anaerobic Conditions. |
Q61448798 | Binding of Elementary Bodies by the Opportunistic Fungal Pathogen or Soluble β-Glucan, Laminarin, Inhibits Infectivity |
Q35848074 | Biofilm models of polymicrobial infection |
Q90295649 | Caenorhabditis elegans as a model animal for investigating fungal pathogenesis |
Q89211305 | Caenorhabditis elegans in high-throughput screens for anti-infective compounds |
Q37979713 | Caenorhabditis elegans, a model organism for investigating immunity |
Q33864072 | Caenorhabditis elegans-based model systems for antifungal drug discovery |
Q27317563 | Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis |
Q42869350 | Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism? |
Q37410095 | Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model |
Q40077323 | Candida and Pseudomonas interact to enhance virulence of mucosal infection in transparent zebrafish. |
Q37942794 | Candida peritonitis: an update on the latest research and treatments |
Q40746229 | Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia |
Q37648725 | Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans |
Q40910127 | Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions |
Q34950943 | Characterization of genetic determinants that modulate Candida albicans filamentation in the presence of bacteria |
Q28750198 | Characterization of mucosal Candida albicans biofilms |
Q26996396 | Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity |
Q35683105 | Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis |
Q37993409 | Complexity and dynamics of host-fungal interactions |
Q37529923 | Cross-kingdom interactions: Candida albicans and bacteria |
Q42074435 | Disarming Fungal Pathogens: Bacillus safensis Inhibits Virulence Factor Production and Biofilm Formation by Cryptococcus neoformans and Candida albicans. |
Q28085214 | Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall |
Q46807780 | Dual-species relations between Candida tropicalis isolated from apple juice ultrafiltration membranes, with Escherichia coli O157:H7 and Salmonella sp. |
Q28475908 | Duckweed (Lemna minor) as a model plant system for the study of human microbial pathogenesis |
Q54293419 | Effects of sequential infections of Caenorhabditis elegans with Staphylococcus aureus and Proteus mirabilis. |
Q34463258 | Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans |
Q41031797 | Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Coinfection Among Adults With Candidemia in Atlanta, GA, 2008-2012. |
Q38005495 | Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections |
Q35738043 | Fungal-bacterial interactions and their relevance in health |
Q42025783 | Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics |
Q41445306 | Genetic Dissection of the Type VI Secretion System in Acinetobacter and Identification of a Novel Peptidoglycan Hydrolase, TagX, Required for Its Biogenesis. |
Q39063044 | Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii |
Q37301677 | Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia |
Q34985477 | Growth inhibition and excessive branching in Aphanomyces cochlioides induced by 2,4-diacetylphloroglucinol is linked to disruption of filamentous actin cytoskeleton in the hyphae. |
Q38013796 | Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection |
Q37832449 | IL-22 in antifungal immunity |
Q36439189 | Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology |
Q37907310 | Implications of interspecies signaling for virulence of bacterial and fungal pathogens. |
Q35076900 | Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model |
Q26822968 | Insights into Acinetobacter baumannii pathogenicity |
Q37190996 | Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium |
Q38752373 | Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota |
Q35080883 | Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system |
Q38192498 | Mechanisms of synergy in polymicrobial infections |
Q37720396 | Medically important bacterial-fungal interactions |
Q39187216 | Microbe-mediated host defence drives the evolution of reduced pathogen virulence |
Q34541225 | Microbial communities of the upper respiratory tract and otitis media in children |
Q33626876 | Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms |
Q35867270 | Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence |
Q34189952 | Modulation of morphogenesis in Candida albicans by various small molecules |
Q38679502 | Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia |
Q55266532 | Multidrug resistant pathogens respond differently to the presence of co-pathogen, commensal, probiotic and host cells. |
Q26799027 | Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections |
Q34067285 | Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates |
Q38103941 | Pneumonia pathogen detection and microbial interactions in polymicrobial episodes |
Q38963858 | Polymicrobial infections involving clinically relevant Gram-negative bacteria and fungi. |
Q64074495 | Pseudomonas aeruginosa inhibits Rhizopus microsporus germination through sequestration of free environmental iron |
Q37268119 | Rapid evolution of microbe-mediated protection against pathogens in a worm host |
Q39991867 | Regulation of Acinetobacter baumannii biofilm formation |
Q34184581 | Repertoire of intensive care unit pneumonia microbiota |
Q36584408 | Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections |
Q40224876 | Role of extracellular polymeric substances in polymicrobial biofilm infections of Staphylococcus epidermidis and Candida albicans modelled in the nematode Caenorhabditis elegans |
Q61806012 | Signal Transduction Proteins in : Role in Antibiotic Resistance, Virulence, and Potential as Drug Targets |
Q39846954 | The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells |
Q54215616 | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
Q50001924 | The Microbial Zoo in the C. elegans Intestine: Bacteria, Fungi and Viruses |
Q90113750 | The Pathobiome in Animal and Plant Diseases |
Q98771335 | The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris |
Q34229719 | The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression |
Q43077801 | The influence of bacterial interaction on the virulence of Cryptococcus neoformans |
Q58723255 | Tipping the Balance: Adaptation in Polymicrobial Environments |
Q64059475 | Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens |
Q33936475 | Using C. elegans for antimicrobial drug discovery |
Q26830123 | pH signaling in human fungal pathogens: a new target for antifungal strategies |
Search more.